These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 34328587)

  • 21. Management of pediatric and adult patients with medulloblastoma.
    Martin AM; Raabe E; Eberhart C; Cohen KJ
    Curr Treat Options Oncol; 2014 Dec; 15(4):581-94. PubMed ID: 25194927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Medulloblastoma in adults].
    Hopf-Jensen S; Buchalla R; Preiß M; Feist H; Börm W; Müller-Hülsbeck S
    Rofo; 2014 Sep; 186(9):825-8. PubMed ID: 25171381
    [No Abstract]   [Full Text] [Related]  

  • 23. Medulloblastomics revisited: biological and clinical insights from thousands of patients.
    Hovestadt V; Ayrault O; Swartling FJ; Robinson GW; Pfister SM; Northcott PA
    Nat Rev Cancer; 2020 Jan; 20(1):42-56. PubMed ID: 31819232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular stratifications, biomarker candidates and new therapeutic options in current medulloblastoma treatment approaches.
    Menyhárt O; Győrffy B
    Cancer Metastasis Rev; 2020 Mar; 39(1):211-233. PubMed ID: 31970590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medulloblastoma: clinical and biologic aspects.
    Packer RJ; Cogen P; Vezina G; Rorke LB
    Neuro Oncol; 1999 Jul; 1(3):232-50. PubMed ID: 11550316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The biologic era of childhood medulloblastoma and clues to novel therapies.
    Khatua S; Zaky W
    Future Oncol; 2014 Mar; 10(4):637-45. PubMed ID: 24754593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metastatic medulloblastoma at diagnosis.
    Gupta S; Pant MC; Husain N; Sundar S
    J Cancer Res Ther; 2011; 7(2):203-4. PubMed ID: 21768715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk-adapted chemotherapy in childhood medulloblastoma.
    Varan A
    Expert Rev Anticancer Ther; 2011 May; 11(5):771-80. PubMed ID: 21554052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oncogenic role of cytomegalovirus in medulloblastoma?
    Hortal AM; Vermeulen JF; Van Hecke W; Bovenschen N
    Cancer Lett; 2017 Nov; 408():55-59. PubMed ID: 28844716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pushing Past the Blockade: Advancements in T Cell-Based Cancer Immunotherapies.
    Waibl Polania J; Lerner EC; Wilkinson DS; Hoyt-Miggelbrink A; Fecci PE
    Front Immunol; 2021; 12():777073. PubMed ID: 34868044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current treatment of medulloblastoma: recent advances and future challenges.
    Rood BR; Macdonald TJ; Packer RJ
    Semin Oncol; 2004 Oct; 31(5):666-75. PubMed ID: 15497120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Medulloblastoma].
    Choux M; Lena G; Alfonsi S; Bernard JL; Clément R; Elbaze F; Gambarelli D; Hassoun J; Lerpinière JP; Lucas C; Pinsard N; Raybaud C; Raybaud C; Rigaud F; Ruffo M; Tapounie E
    Neurochirurgie; 1982; 28 Suppl 1():1-229. PubMed ID: 7110502
    [No Abstract]   [Full Text] [Related]  

  • 33. Childhood medulloblastoma: progress and future challenges.
    Packer RJ
    Brain Dev; 1999 Mar; 21(2):75-81. PubMed ID: 10206522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Challenges and Recent Advances in Medulloblastoma Therapy.
    Kumar V; Kumar V; McGuire T; Coulter DW; Sharp JG; Mahato RI
    Trends Pharmacol Sci; 2017 Dec; 38(12):1061-1084. PubMed ID: 29061299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medulloblastoma-biology and microenvironment: a review.
    Byrd T; Grossman RG; Ahmed N
    Pediatr Hematol Oncol; 2012 Sep; 29(6):495-506. PubMed ID: 22742590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebellopontine angle medulloblastoma.
    Nyanaveelan M; Azmi A; Saffari M; Banu SK; Suryati MY; Jeyaledchumy M
    Med J Malaysia; 2007 Jun; 62(2):173-4. PubMed ID: 18705459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting Angiogenic Factors for the Treatment of Medulloblastoma.
    Saker Z; Rizk M; Bahmad HF; Nabha SM
    Curr Treat Options Oncol; 2022 Jun; 23(6):864-886. PubMed ID: 35412196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current studies and future directions for medulloblastoma: A review from the pacific pediatric neuro-oncology consortium (PNOC) disease working group.
    Cooney T; Lindsay H; Leary S; Wechsler-Reya R
    Neoplasia; 2023 Jan; 35():100861. PubMed ID: 36516489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical treatment and outcome of cerebellopontine angle medulloblastoma: a retrospective study of 15 cases.
    Wu T; Qu PR; Zhang S; Li SW; Zhang J; Wang B; Liu P; Li CD; Zhao F
    Sci Rep; 2020 Jun; 10(1):9769. PubMed ID: 32555264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of pediatric average-risk medulloblastoma using craniospinal irradiation less than 2500 cGy and chemotherapy: single center experience in Korea.
    Yoon JH; Park KD; Kang HJ; Kim H; Lee JW; Kim SK; Wang KC; Park SH; Kim IH; Shin HY
    World J Pediatr; 2017 Aug; 13(4):367-373. PubMed ID: 28550392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.